Non-Phthalate Medical PVC Plasticizers: Replacing DEHP in IV Bags, Catheters & Blood Tubing
Why the industry is moving off DEHP - and how to pick a low-migration, biocompatible alternative.
Rigid PVC has to be softened to become the flexible tubing, bags and catheters used throughout healthcare - and for decades that softening was done with DEHP. It was inexpensive, effective and easy to process. The problem is that DEHP is not chemically bound to the PVC: it migrates out over time, especially into blood, lipids and certain drug solutions. Combined with its classification as a reproductive toxicant, that has made non-phthalate alternatives the direction of travel for medical PVC. 🩺
⚠️ Why DEHP is being phased out of medical PVC
Two issues drive the shift, and they compound each other:
1️⃣ Migration / leaching
Because it is only physically dissolved in the polymer, DEHP leaches into contacting fluids - a concern in IV therapy, blood transfusion, dialysis, ECMO and parenteral nutrition, where the extracted dose can be meaningful, particularly for sensitive patients.
2️⃣ Regulatory classification
DEHP is classified as a reproductive toxicant (Repr. 1B) and sits on the EU ECHA SVHC Candidate List. The U.S. CPSC restricts it in children's articles, and the FDA has advised minimising exposure for high-risk procedures and sensitive populations.
The honest picture: human-health evidence has been debated for years, and DEHP is still legally used in many devices. But the combined regulatory and reputational pressure means most manufacturers now want a non-phthalate story for new products. ✅
🔬 What makes a plasticizer "medical grade"
A medical PVC plasticizer has to clear a higher bar than an industrial one:
🔹 Low migration / extractables - the single most important property for fluid-contact devices.
🔹 Biocompatibility - evaluated under ISO 10993 for cytotoxicity, irritation, sensitisation and more.
🔹 No CMR classification - not carcinogenic, mutagenic or toxic to reproduction.
🔹 Sterilisation stability - must survive gamma, ethylene-oxide or steam sterilisation without degrading or discolouring.
🔹 Clarity & processability - good optical clarity and clean compounding behaviour.
🧪 The main non-phthalate options
DINCH (cyclohexanoate)
Specifically developed for sensitive-contact uses with a favourable toxicological profile. A common first-choice replacement where its performance is sufficient.
TOTM (trimellitate)
A higher-molecular-weight aromatic ester with low migration - long used in blood bags and tubing where leaching must be minimised.
TOPM (pyromellitate) 🌡️
The tetra-ester step beyond TOTM: the highest molecular weight of the aromatic ester family, giving the lowest volatility and extractables, with a non-CMR profile suited to the most demanding low-migration medical PVC. See the TOPM product page for specifications, and TOPM vs TOTM for how the extra ester group lowers migration.
Citrates (ATBC) & terephthalates (DEHT/DOTP)
Citrates offer a bio-based, low-toxicity story for the most sensitive niches; terephthalates serve more general flexible-PVC needs. Both trade some performance for their particular advantage.
💧 Migration is device-specific - match the plasticizer to the duty
There is no single "best" medical plasticizer; the right choice depends on how aggressively the device extracts it:
| Device | Migration challenge | Priority |
|---|---|---|
| IV & solution bags | Long contact, sometimes lipophilic drugs | Very low extractables |
| Blood / transfusion tubing & bags | Direct blood contact, lipid extraction | Low migration + biocompatibility |
| Catheters | Tissue contact, flexibility & kink resistance | Biocompatibility + softness retention |
| Dialysis / ECMO circuits | High-volume, prolonged blood contact | Lowest possible leaching |
Directional guidance only - always validate against your device's contact conditions and applicable regulation.
🎯 Where TOPM fits
For the most extraction-prone devices - long-dwell IV bags, blood-contact and extracorporeal circuits - where you want to push leaching as low as possible, the pyromellitate ester TOPM's high molecular weight and low extractables make it a strong candidate. For less aggressive contact, a lighter option such as DINCH or a citrate may be sufficient and more economical. Browse the full plasticizers range to compare. 🔗
💡 A realistic note on switching: replacing DEHP is never a drop-in. Any alternative changes processing, softness and migration behaviour, so it requires re-validation, biocompatibility testing under ISO 10993, and updated regulatory documentation. Plan the switch as a project, not a substitution.
❓ Frequently asked questions
🔹 Is DEHP banned in medical devices?
Not universally. It is restricted in children's articles and under growing pressure in the EU, and regulators advise minimising exposure for sensitive procedures - but it is still legally used in many devices. The market trend is toward non-phthalate alternatives for new products.
🔹 Which non-phthalate plasticizer has the lowest migration?
Among the common options, the high-molecular-weight aromatic esters - trimellitates (TOTM) and especially pyromellitates (TOPM) - offer the lowest migration, which is why they are favoured for blood-contact and long-dwell devices.
🔹 Does a non-phthalate plasticizer automatically pass biocompatibility?
No. "Non-phthalate" and "biocompatible" are different claims. Every finished device must be evaluated under ISO 10993 regardless of which plasticizer is used.
🔹 Can I use the same plasticizer for every medical device?
You can, but it is often over- or under-specified. Match the plasticizer to the device's extraction severity - a low-dwell item does not need the lowest-migration ester, while a blood circuit does.
🔗 Related articles
Biocompatibility, extraction testing and regulatory pathways.
📞 Selecting a plasticizer for a medical PVC device?
Tell us the device, contact conditions and sterilisation method - we'll help you weigh non-phthalate options including TOPM for the lowest migration, with samples and documentation to support your validation.
